Jinguo Zhang

8PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 14, 2026
BRD4 orchestrates the metabolic-epigenetic regulation of GM-CSF expression and secretion to drive PD-L1⁺ macrophage-mediated immune evasion in triple-negative breast cancer.

Haizhou Diao, Jingxiong Chen, Yan Zhang

|Mar 02, 2025
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.

Mengting Wan, Shuaikang Pan, Benjie Shan

|Feb 12, 2025
CD1B Expression in Triple-Negative Breast Cancer: Its Implications for Prognosis and Immunotherapy Outcomes.

Hongwei Jin, Mengting Wan, Shuaikang Pan

|Jul 08, 2024
LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer.

Shuaikang Pan, Mengting Wan, Hongwei Jin

|Dec 23, 2022
Systematic Investigation of the Multifaceted Role of SOX11 in Cancer.

Qingqing Sun, Jun Du, Jie Dong

|Nov 11, 2022
Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast Cancer.

Jinguo Zhang, Shuaikang Pan, Chaoqiang Han

Pageof 2

Frequent Collaborators

5 joint publications

Xinghua Han

3 joint publications

Yueyin Pan

1 joint publications

Wencai Guan

1 joint publications

Xiaolin Xu